House Bill Would Cut HHS Budget By 6%, CDC By 19% And Eliminate AHRQ
The fate of the Agency for Healthcare Research and Quality (AHRQ) hangs in the balance as the Trump Administration and the House Appropriations Committee consider eliminating the agency. Established in 1999 through bipartisan efforts, AHRQ has been a key player in healthcare safety and quality research. However, the recent proposed budget from the House committee does not include AHRQ, citing it as “duplicative” without providing specific details.
The potential elimination of AHRQ raises concerns about the impact on healthcare quality and safety. Over the years, AHRQ has published influential reports on patient safety practices, healthcare quality, and healthcare disparities. The agency has funded research projects aimed at reducing medical errors, healthcare-associated infections, and improving quality of care. Without AHRQ, the future of funding for such vital research remains uncertain, potentially hindering efforts to make healthcare safer and more effective.
Furthermore, the House bill proposes significant cuts to the U.S. Department of Health and Human Services budget, including a 19% reduction in the Centers for Disease Control and Prevention (CDC) budget. The rationale behind these cuts is to focus the CDC on communicable diseases and combat emerging infectious diseases. However, the complex interplay between communicable and non-communicable diseases, as well as the impact of social factors on disease spread, cannot be overlooked.
The House bill is set to undergo further review and modification by the House Appropriations Committee before being voted on by the House of Representatives. While there is still a possibility for AHRQ to be saved, the current budget proposal does not bode well for the agency. The future of healthcare safety and quality research hinges on the decisions made by Congress in the coming months.
